Amanote Research
Register
Sign In
Evolution of a New Class of VEGFR2 Inhibitors From Scaffold Morphing and Redesign
doi 10.1021/acsmedchemlett.5b00486.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Kinase Inhibitors: A New Class of Antirheumatic Drugs
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Farnesyltransferase Inhibitors: A New Class of Cancer Chemotherapeutics
Biochemical Society Transactions
Biochemistry
New Potent P-Glycoprotein Inhibitors Carrying a Polycyclic Scaffold
New Inhibitors of DNA Methyltransferase 1 Based on Cytosine Scaffold
Biotechnologia
Biotechnology
Plant Science
A New Class of Inhibitors of Peptide Sorption and Acylation in PLGA
Journal of Controlled Release
Pharmaceutical Science
Immune Response Checkpoint Inhibitors: New Risks of a New Class of Antitumor Agents
Safety and Risk of Pharmacotherapy
Discovery and Refinement of a New Structural Class of Potent Peptide Deformylase Inhibitors
“Reverse” Carbocyclic Fleximers: Synthesis of a New Class of Adenosine Deaminase Inhibitors
Nucleosides, Nucleotides and Nucleic Acids
Medicine
Biochemistry
Genetics
Molecular Medicine
Alogliptin: A New Addition to the Class of DPP-4 Inhibitors
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology